| Peter A Roloff, MD | |
|
1215 George Towne Dr, Pewaukee, WI 53072-2731 | |
| (262) 691-3849 | |
| (262) 691-4287 |
| Full Name | Peter A Roloff |
|---|---|
| Gender | Male |
| Speciality | Pediatric Medicine |
| Experience | 27 Years |
| Location | 1215 George Towne Dr, Pewaukee, Wisconsin |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1023002110 | NPI | - | NPPES |
| 32626800 | Medicaid | WI |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208000000X | Pediatrics | 41886 (Wisconsin) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Ascension Medical Group-fox Valley Wisconsin Inc | 0244142420 | 258 |
News Archive
Halozyme Therapeutics, Inc. today announced Phase 2 results demonstrating that the subcutaneous coinjection of rHuPH20 (recombinant human hyaluronidase, PH20) with lispro significantly improves postprandial hyperglycemia, reduces hypoglycemia, and accelerates the absorption of mealtime insulin in patients with type 2 diabetes.
President Joe Biden's edict that nursing homes must ensure their workers are vaccinated against covid-19 presents a challenge for an industry struggling to entice its lowest-paid workers to get shots without driving them to seek employment elsewhere.
Health experts have been saying that mobile phones are bad for us for a long time. Now they are getting set to prove it beyond any doubt. Researchers in London recently launched the world's largest study on the safety of using mobile phones. A quarter of a million mobile phone users will be tracked through their medical records for more than 20 years. This is the largest study in the world on the health effects of using mobile phones and is being called Cosmos.
Performing less invasive laparoscopic surgery using robotic technology may improve survival rates for prostate cancer patients, according to a study by urologic oncologists at Thomas Jefferson University Hospital's multidisciplinary Genitourinary (GU) cancer center.
ThermoGenesis Corp. (Nasdaq: KOOL), a leading supplier of innovative products for processing and storing adult stem cells, said today it had received a letter dated September 16, 2009, indicating the Company had become non-compliant with the Nasdaq Capital Markets' minimum bid pricing requirement under rule 5550(a)(2) as the Company's closing bid price for the past 30 days had failed to meet the minimum bid of $1.00 per share.
› Verified 8 days ago
| Entity Name | Ascension Medical Group-fox Valley Wisconsin Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1730126392 PECOS PAC ID: 0244142420 Enrollment ID: O20031105000351 |
News Archive
Halozyme Therapeutics, Inc. today announced Phase 2 results demonstrating that the subcutaneous coinjection of rHuPH20 (recombinant human hyaluronidase, PH20) with lispro significantly improves postprandial hyperglycemia, reduces hypoglycemia, and accelerates the absorption of mealtime insulin in patients with type 2 diabetes.
President Joe Biden's edict that nursing homes must ensure their workers are vaccinated against covid-19 presents a challenge for an industry struggling to entice its lowest-paid workers to get shots without driving them to seek employment elsewhere.
Health experts have been saying that mobile phones are bad for us for a long time. Now they are getting set to prove it beyond any doubt. Researchers in London recently launched the world's largest study on the safety of using mobile phones. A quarter of a million mobile phone users will be tracked through their medical records for more than 20 years. This is the largest study in the world on the health effects of using mobile phones and is being called Cosmos.
Performing less invasive laparoscopic surgery using robotic technology may improve survival rates for prostate cancer patients, according to a study by urologic oncologists at Thomas Jefferson University Hospital's multidisciplinary Genitourinary (GU) cancer center.
ThermoGenesis Corp. (Nasdaq: KOOL), a leading supplier of innovative products for processing and storing adult stem cells, said today it had received a letter dated September 16, 2009, indicating the Company had become non-compliant with the Nasdaq Capital Markets' minimum bid pricing requirement under rule 5550(a)(2) as the Company's closing bid price for the past 30 days had failed to meet the minimum bid of $1.00 per share.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Peter A Roloff, MD 1215 George Towne Dr, Pewaukee, WI 53072-2731 Ph: (262) 691-3849 | Peter A Roloff, MD 1215 George Towne Dr, Pewaukee, WI 53072-2731 Ph: (262) 691-3849 |
News Archive
Halozyme Therapeutics, Inc. today announced Phase 2 results demonstrating that the subcutaneous coinjection of rHuPH20 (recombinant human hyaluronidase, PH20) with lispro significantly improves postprandial hyperglycemia, reduces hypoglycemia, and accelerates the absorption of mealtime insulin in patients with type 2 diabetes.
President Joe Biden's edict that nursing homes must ensure their workers are vaccinated against covid-19 presents a challenge for an industry struggling to entice its lowest-paid workers to get shots without driving them to seek employment elsewhere.
Health experts have been saying that mobile phones are bad for us for a long time. Now they are getting set to prove it beyond any doubt. Researchers in London recently launched the world's largest study on the safety of using mobile phones. A quarter of a million mobile phone users will be tracked through their medical records for more than 20 years. This is the largest study in the world on the health effects of using mobile phones and is being called Cosmos.
Performing less invasive laparoscopic surgery using robotic technology may improve survival rates for prostate cancer patients, according to a study by urologic oncologists at Thomas Jefferson University Hospital's multidisciplinary Genitourinary (GU) cancer center.
ThermoGenesis Corp. (Nasdaq: KOOL), a leading supplier of innovative products for processing and storing adult stem cells, said today it had received a letter dated September 16, 2009, indicating the Company had become non-compliant with the Nasdaq Capital Markets' minimum bid pricing requirement under rule 5550(a)(2) as the Company's closing bid price for the past 30 days had failed to meet the minimum bid of $1.00 per share.
› Verified 8 days ago
Dr. Bonnie-jo Mclean Grieve, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: W262n2442 Deer Haven Dr, Pewaukee, WI 53072 Phone: 414-510-0603 Fax: 414-691-1911 | |
Bethany Ann Weinert, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 1215 George Towne Drive, Pewaukee, WI 53072 Phone: 262-691-3849 Fax: 262-691-4287 | |
Dr. Karen A Swanson, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 1215 George Towne Dr, Pewaukee, WI 53072 Phone: 262-691-3849 Fax: 262-691-4287 | |
Dr. James E Shander, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 1215 George Towne Dr, Pewaukee, WI 53072 Phone: 262-691-3849 Fax: 262-691-4287 | |
Anjali Jain Sharma, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 1215 George Towne Drive, Pewaukee, WI 53072 Phone: 262-691-3843 Fax: 262-691-4287 | |
Dr. Stephanie L Whitt, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 1215 George Towne Drive, Pewaukee, WI 53072 Phone: 262-691-3849 Fax: 262-691-4287 |